The latest news & events

Keep up to date with company updates, industry news, investor
press releases and event information.

Events : 22 May 2019

Kneat to support leading Bio-Manufacturing event, BioTalk USA

Join us at BioTalk, Biological Manufacturing Excellence, May 22-23, Boston The 2019 BioTalk USA, Biological Manufacturing Excellence conference, takes place…

Read More
Investor News - General : 1 May 2019

Kneat Appoints SaaS Industry Veteran, Rory Cameron, as New Board Member

HALIFAX, May 1, 2019/CNW/ –, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that Mr. Rory Cameron has been appointed to its Board of Directors. Mr. Cameron has over 15 years of experience in the software industry and an extensive background in mergers, acquisitions and go-to-market

Read More
Investor News - General : 24 Apr 2019

Kneat Reports Fourth Quarter Results

HALIFAX, April 24, 2019/CNW/ –, inc. (TSX-V: KSI) (“Kneat”) today announced its financial results for the quarter and year ended December 31, 2018. All dollar amounts are presented in Canadian dollars unless otherwise stated. Fourth Quarter Highlights Revenue of $465,205 was recognized

Read More
News : 16 Apr 2019

April 16, 2019 | Kneat Launches Annual ‘Customer Summit’ to Enable Customer-Driven Development

HALIFAX, April 16, 2019/– Kneat is pleased to announce the launch of the inaugural Kneat Customer Summit, the first in…

Read More
Investor News - General : 11 Apr 2019

Kneat to Present at Bloom Burton & Co. Healthcare Investor Conference

HALIFAX, April 11, 2019/CNW/ –, inc. (TSX-V: KSI) (“Kneat”) announced today that it will be presenting at the 2019 Bloom Burton & Co. Healthcare Investor Conference. The details of Kneat’s presentation include: Date:  Wednesday, May 1, 2019 Time:  11:30 AM EST Location:  Metro Toronto

Read More
Investor News - General : 11 Mar 2019

Kneat Signs Global Biotechnology Leader

HALIFAX, March 11, 2019/CNW/ –, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that an international leader in biotechnology has chosen Kneat’s software platform to facilitate its transition to paperless validation processes. With over 20,000 employees globally and manufacturing

Read More
Investor News - General : 7 Mar 2019

Kneat Announces Grant of Stock Options

HALIFAX, NS / March 7, 2019 /, inc. (TSXV: KSI) (“Kneat”) announces that the board of directors of the Company has approved the granting of 293,000 incentive stock options (the “Options”) pursuant to the Company’s Stock Option Plan. Officers were awarded 293,000 stock options that are

Read More
News : 28 Feb 2019

February 28, 2019 | FDA’s New Continuous Manufacturing Guidance Carries Process Validation Implications

In a new 27-page Guidance, ‘Quality Considerations for Continuous Manufacturing’, released February 27, 2019, the FDA and CDER (Center for…

Read More
Investor News - General : 21 Feb 2019

Kneat and HCL Technologies Partner to Deliver Digital Validation Solutions to Life Sciences

HALIFAX, February 21, 2019/CNW/ –, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it has signed a partnership agreement with HCL Technologies (“HCL”), a leading global technology company, to provide innovative end-to-end digital validation solutions to customers in the life

Read More
Investor News - General : 20 Feb 2019

Kneat closes equity financings totalling over $8.5M

Not for distribution to United States newswire services or for dissemination in the United States HALIFAX, Feb 20, 2019 /CNW/ –, inc. (TSXV: KSI) (“Kneat” or the “Company”) is pleased to announce that it has closed its previously announced short form prospectus offering, including the

Read More
Investor News - General : 14 Feb 2019

Recently Signed Customer Scales Kneat’s platform to Second Site

HALIFAX, February 14, 2019/CNW/ –, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that a top tier global healthcare customer is expanding their use of the Kneat platform to a new manufacturing site. This customer was signed in July 2018, went live at their primary European site in

Read More
Investor News - General : 13 Feb 2019

Kneat announces customer expansion at flagship US site and provides financing update

HALIFAX, February 13, 2019/CNW/ –, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that a leading laboratory services customer is expanding its user base on the Kneat platform within its flagship site in the United States. This expansion will double the customer’s license numbers.

Read More

Sign Up to Our Newsletter


Talk to us

Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.

Europe: +353-61-203826
U.S: +1 888 88 KNEAT
Canada: +1 902 706 9074